Navigation Links
Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
Date:11/12/2012

osis and one death, a myocardial infarction secondary to community-acquired pneumonia, were reported in the I.V. golimumab group.  Through week 52, the proportions of infusions and patients with infusion reactions were 0.7 percent and 3.6 percent, respectively, (versus 1.1 percent and 3.5 percent at week 24, respectively).

About GO-FURTHER
The GO-FURTHER trial is a Phase 3, international multicenter, double-blind, placebo-controlled study including 592 adults with RA designed to compare ACR 20 response at week 14 in patients receiving an I.V. golimumab infusion  plus methotrexate compared with patients receiving placebo infusions plus methotrexate. The trial included patients diagnosed with active RA who had at least six tender and six swollen joints and who had been receiving background methotrexate for at least three months. Patients were randomized 2:1 to receive a 30 (+/- 10) minute I.V. infusion of golimumab  2 mg/kg or placebo plus methotrexate at weeks 0, 4, and then every eight weeks.  The primary endpoint of the study was ACR 20 at week 14.  At week 16, patients receiving placebo with less than 10 percent improvement in combined swollen and tender joint counts were entered into early escape to receive I.V. golimumab 2 mg/kg at week 16 and week 20.  All patients receiving placebo crossed over to I.V. golimumab at week 24. Radiographs of the hands and feet were taken at baseline, week 24 (week 16 for early escape participants) and week 52 and were scored using the modified vdHS score.  Week 24 results from the Janssen-sponsored study were presented earlier this year at the 2012 EULAR Annual Congress and also appeared in the Annals of the Rheumatic Diseases.

About Rheumatoid Arthritis 
Rheumatoid Arthr
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 The western European automated endoscope ... largely a replacement market with fewer new installations ... and partnerships are redefining competitive landscape in western ... provides details about revenue forecasts, unit shipments, market ... the country. The changing landscape makes it important ...
(Date:9/22/2014)... , Sept. 22, 2014 Research and ... Market for Neurotechnology: 2014-2018" report to their offering. ... is the most comprehensive and up-to-date publication available covering ... at the technology, markets, competitors, and growth rates in ... years 2014 through 2018. It forecasts the number of ...
(Date:9/22/2014)... , Sept. 22, 2014 Children,s ... of Monday, Sept. 29 at 5 p.m. EDT ... Kids!" competition, in response to continued strong interest ... $50,000 each will be awarded to the winning ... Surgical Innovation Symposium hosted by Children,s National in ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3The Market for Neurotechnology: 2014-2018 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3
... 14, 2011 OCuSOFT, Inc., an ophthalmic pharmaceutical research, ... agreement with Ardeo Health, LLC to distribute a novel ... of Evry, France, Nova23041. Nova23041 will be ... as Retaine® MGD™ Ophthalmic Emulsion under a brand license ...
... Better Health ™, a program of Lilly USA, LLC, ... healthier, more active lives, launches an enhanced multi-channel platform ... health information. The platform includes an array of patient ... manage their health, a dynamic website – lillyforbetterhealth.com ...
Cached Medicine Technology:Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT® 2Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT® 3Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform 2Lilly for Better Health™ Launches Enhanced Multi-Channel Patient Education Platform 3
(Date:9/22/2014)... leather seat covers offered by Lseat.com are meticulously in ... to meet customers’ specific product needs and budget level. The ... leather seat covers . Furthermore, the firm has launched an ... the new range is now available at a discounted rate ... are produced, the company’s top designers also carefully pick out ...
(Date:9/22/2014)... Fashion Footwear Association of New York (FFANY) and leading ... research to the University of Pittsburgh Cancer Institute (UPCI), ... the proceeds of the 20th annual QVC Presents "FFANY ... several cancer research centers across the country, including UPCI ... has been selected to receive funds from this year,s ...
(Date:9/22/2014)... September 22, 2014 On Saturday, September 27, ... Playworks, a local nonprofit that is doing an amazing job ... including UHY employees, their families and friends will be spending ... paint on cement games and graphics, as well as clean ... was originally scheduled to occur in May but due to ...
(Date:9/22/2014)... and young adults at risk for sexually transmitted infections ... sexual behaviors, according to new recommendations from the U.S. ... million new sexually transmitted infections such as gonorrhea and ... people between 15 and 24 years old, according to ... Sept. 22 in Annals of Internal Medicine , ...
(Date:9/22/2014)... By Amy Norton ... -- Tiny preemies may fare better when newborn intensive care ... time with their infants, a new study finds. Researchers ... were more alert and were less distressed when their NICU ... families. The findings, published online Sept. 22 in the ...
Breaking Medicine News(10 mins):Health News:Great 2007-2012 Jeep Wrangler JK Real Leather Seat Covers Introduced by Lseat.com 2Health News:Heels for a cause: FFANY, QVC Present $240,000 from shoe sales to Pitt researchers 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3
... of Healthcare Startup, NEW YORK, Aug. 19 ... book doctor appointments online, today announced it has,completed ... led by Khosla Ventures.,ZocDoc is the first consumer ... http://www.newscom.com/cgi-bin/prnh/20080819/LATU010LOGO ), ZocDoc uses the Internet to ...
... today a 3-year agreement with Aetna (AET) that will ... metro markets in,Florida, Texas and Georgia., "Aetna long ... and,advocacy for timely and appropriate end-of-life care, with programs ... Innovative Hospice,Care. "As a hospice pioneer and innovator, VITAS ...
... Mental, Physical And Behavioral ... Performance In School-age Children, CABOT, Vt., Aug. 19 Who ... with a healthy breakfast? Apparently more folks,than you might ever imagine. ... and 32 percent of boys who are,of school age, skip breakfast ...
... Coverage for Wheelchairs,Oxygen, and Other Home Medical Equipment and ... out of,four (74 percent) American voters agree that, "home ... rapidly increasing Medicare spending for,America,s seniors." Voters age 55-plus ... national telephone survey of 1,000 American adults conducted by,Harris ...
... years as an industry leader in successful medical practice management ... ... August 19, 2008 -- http://www.hollanderconsultants.com [Hollander Consultants] was ... has focused on delivering consulting and training services to doctors ...
... August 19, 2008 Men with signs of benign ... dose of erectile dysfunction drug tadalafil (Cialis) to relieve ... new study published in the October 2008 issue of ... University of Texas Southwestern Medical Center at Dallas, Northwestern ...
Cached Medicine News:Health News:Khosla Ventures Into Healthcare With ZocDoc 2Health News:VITAS Innovative Hospice Care Signs Agreement with Aetna 2Health News:VITAS Innovative Hospice Care Signs Agreement with Aetna 3Health News:Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year 2Health News:Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year 3Health News:Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year 4Health News:Preparing To Send Your Children Off To School? Healthy Breakfast, Lunch and Snack Ideas From Cabot(R) Can Contribute to a Better, More Productive School Year 5Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 2Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 3Health News:Hollander Consultants Celebrates 25 Years as an Industry Leader in Successful Medical Practice Management Consulting 2Health News:Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 2
Shoulder Subluxation Inhibitor (SSI) is an ideal bracing system to keep athletes on the field by reducing the risk of shoulder injury. The SSI is the only brace that allows TOTAL ANTERIOR RANGE OR MO...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... single size, the Sierra Universal Collar fits the ... the comfort and motion restriction needed to protect ... the right size for the right fit . ... size and compact design alleviate storage problems, the ...
... spinal bracing is a critical component of ... stabilization. The Aspen® Lumbosacral Bracing System™ offers ... a high degree of immobilization, unparalled comfort, ... . . . even if they gain ...
Medicine Products: